{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:07:04Z","timestamp":1785539224537,"version":"3.56.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T00:00:00Z","timestamp":1657411200000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL131844"],"award-info":[{"award-number":["R01 HL131844"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL 119225"],"award-info":[{"award-number":["R01 HL 119225"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17PRE33661114"],"award-info":[{"award-number":["17PRE33661114"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010519","name":"Louisiana State University Health Sciences Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.atherosclerosis.2021.06.927","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T11:16:22Z","timestamp":1625138182000},"page":"76-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Myeloid-associated lipin-1 transcriptional co-regulatory activity is atheroprotective"],"prefix":"10.1016","volume":"330","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6589-5349","authenticated-orcid":false,"given":"Cassidy M.R.","family":"Blackburn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7584-8282","authenticated-orcid":false,"given":"Robert M.","family":"Schilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5928-8844","authenticated-orcid":false,"given":"Aimee E.","family":"Vozenilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3887-2360","authenticated-orcid":false,"given":"Sunitha","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1628-8868","authenticated-orcid":false,"given":"Temitayo T.","family":"Bamgbose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5411-3674","authenticated-orcid":false,"given":"Brian N.","family":"Finck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8497-5838","authenticated-orcid":false,"given":"Matthew D.","family":"Woolard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2021.06.927_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fcvm.2017.00086","article-title":"Mechanisms and consequences of defective efferocytosis in atherosclerosis","volume":"4","author":"Yurdagul","year":"2017","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.06.927_bib2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/ATVBAHA.117.310455","article-title":"Macrophage-associated lipin-1 enzymatic activity contributes to modified low-density lipoprotein-induced proinflammatory signaling and atherosclerosis","volume":"38","author":"Vozenilek","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.06.927_bib3","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.06.927_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0733-8651(03)00079-1","article-title":"C-reactive protein, inflammation, and coronary risk","volume":"21","author":"Ridker","year":"2003","journal-title":"Cardiol. Clin."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.06.927_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/joim.12406","article-title":"Inflammation and plaque vulnerability","volume":"278","author":"Hansson","year":"2015","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.06.927_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pcad.2008.09.001","article-title":"Atherosclerotic plaque stability--what determines the fate of a plaque?","volume":"51","author":"Halvorsen","year":"2008","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.06.927_bib7","first-page":"136","article-title":"CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima","volume":"119","author":"Park","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.06.927_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2796.2000.00655.x","article-title":"Modified LDL - trigger of atherosclerosis and inflammation in the arterial intima","volume":"247","author":"Pentik\u00e4inen","year":"2000","journal-title":"J. Intern. Med."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.06.927_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bbalip.2009.01.005","article-title":"Leukocyte lipid bodies - biogenesis and functions in inflammation","volume":"1791","author":"Bozza","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.06.927_bib10","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1083\/jcb.97.4.1156","article-title":"Morphological characterization of the cholesteryl ester cycle in cultured mouse macrophage foam cells","volume":"97","author":"McGookey","year":"1983","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.06.927_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","article-title":"Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages","volume":"167","author":"Mills","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2021.06.927_bib12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.yjmcc.2019.01.003","article-title":"Macrophage fatty acid oxidation inhibits atherosclerosis progression","volume":"127","author":"Nomura","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.06.927_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ni.3366","article-title":"Fatty acid oxidation in macrophage polarization","volume":"17","author":"Nomura","year":"2016","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.06.927_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0092-8674(00)81574-3","article-title":"Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma","volume":"93","author":"Nagy","year":"1998","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.06.927_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MOL.0b013e32832adee5","article-title":"The lipin family: mutations and metabolism","volume":"20","author":"Reue","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"issue":"Suppl","key":"10.1016\/j.atherosclerosis.2021.06.927_bib16","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1194\/jlr.R800052-JLR200","article-title":"Lipin proteins and metabolic homeostasis","volume":"50","author":"Reue","year":"2009","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.06.927_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.atherosclerosis.2015.08.012","article-title":"Lipin-1 contributes to modified low-density lipoprotein-elicited macrophage pro-inflammatory responses","volume":"242","author":"Navratil","year":"2015","journal-title":"Atherosclerosis"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2021.06.927_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97506","article-title":"The phosphatidic acid phosphatase lipin-1 facilitates inflammation-driven colon carcinogenesis","volume":"3","author":"Meana","year":"2018","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2021.06.927_bib19","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.4049\/jimmunol.1400238","article-title":"Lipin-1 integrates lipid synthesis with proinflammatory responses during TLR activation in macrophages","volume":"193","author":"Meana","year":"2014","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2021.06.927_bib20","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1161\/ATVBAHA.108.171538","article-title":"Alterations in hepatic metabolism in fld mice reveal a role for lipin 1 in regulating VLDL-triacylglyceride secretion","volume":"28","author":"Chen","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.06.927_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cmet.2006.08.005","article-title":"Lipin 1 is an inducible amplifier of the hepatic PGC-1 alpha\/PPARalpha regulatory pathway","volume":"4","author":"Finck","year":"2006","journal-title":"Cell Metabol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.06.927_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/BJ20121598","article-title":"Lipin 1 regulates PPAR\u03b3 transcriptional activity","volume":"453","author":"Kim","year":"2013","journal-title":"Biochem. J."},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2021.06.927_bib23","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1185\/030079905X36440","article-title":"PPARgamma and atherosclerosis","volume":"21","author":"Staels","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"issue":"26","key":"10.1016\/j.atherosclerosis.2021.06.927_bib24","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.2174\/092986706778742909","article-title":"PPARgamma activity in the vessel wall: anti-atherogenic properties","volume":"13","author":"Reiss","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.06.927_bib25","series-title":"ImmunoHorizons","article-title":"Macrophage-associated lipin-1 promotes \u03b2-oxidation in response to proresolving stimuli","author":"Schilke","year":"2020"},{"key":"10.1016\/j.atherosclerosis.2021.06.927_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.yjmcc.2019.01.003","article-title":"Macrophage fatty acid oxidation inhibits atherosclerosis progression","author":"Nomura","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.06.927_bib27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-2275(20)32011-3","article-title":"Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene","volume":"41","author":"Reue","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2021.06.927_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.atherosclerosis.2018.09.005","article-title":"AAV8-mediated overexpression of mPCSK9 in liver differs between male and female mice","volume":"278","author":"Vozenilek","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.06.927_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/01.STR.0000196986.50059.e0","volume":"37","author":"Sluijter","year":"2006","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.06.927_bib30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.ATV.12.4.494","article-title":"Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies","volume":"12","author":"Katsuda","year":"1992","journal-title":"Arterioscler. Thromb."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.06.927_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600224","article-title":"Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis","volume":"2","author":"Karunakaran","year":"2016","journal-title":"Sci Adv"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.06.927_bib32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1189\/jlb.0209115","article-title":"Mechanisms and consequences of efferocytosis in advanced atherosclerosis","volume":"86","author":"Thorp","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.06.927_bib33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00395-011-0192-x","article-title":"Necrotic cell death in atherosclerosis","volume":"106","author":"Martinet","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.06.927_bib34","series-title":"Mathematical Medicine and Biology: A Journal of the IMA","article-title":"Growth of necrotic cores in atherosclerotic plaque","author":"Fok","year":"2012"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.06.927_bib35","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1161\/CIRCRESAHA.116.304794","article-title":"Identification of a non-growth factor role for GM-CSF in advanced atherosclerosis: promotion of macrophage apoptosis and plaque necrosis through IL-23 signaling","volume":"116","author":"Subramanian","year":"2015","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.06.927_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2337\/db07-0083","article-title":"Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans","volume":"57","author":"Wiedmann","year":"2008","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.06.927_bib37","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9440(10)64641-X","article-title":"Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death","volume":"157","author":"Kolodgie","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.06.927_bib38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/CS20040086","article-title":"Role of apoptosis in atherosclerosis and its therapeutic implications","volume":"107","author":"Stoneman","year":"2004","journal-title":"Clin. Sci. (Lond.)"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.06.927_bib39","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/ATVBAHA.119.313640","article-title":"Loss of MLKL (mixed lineage kinase domain-like protein) decreases necrotic core but increases macrophage lipid accumulation in atherosclerosis","volume":"40","author":"Rasheed","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.06.927_bib40","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/ATVBAHA.120.315758","article-title":"Resolvin D1 enhances necroptotic cell clearance through promoting macrophage fatty acid oxidation and oxidative phosphorylation","volume":"41","author":"Hosseini","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.06.927_bib41","series-title":"Stroke","article-title":"Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23\/interleukin 17 axis","author":"Abbas","year":"2015"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2021.06.927_bib42","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1089\/jir.2019.0050","article-title":"The effects of anti-IL-23p19 therapy on atherosclerosis development in ApoE","volume":"39","author":"Wang","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2021.06.927_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008257","article-title":"IL-23R deficiency does not impact atherosclerotic plaque development in mice","volume":"7","author":"Engelbertsen","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2021.06.927_bib44","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1073\/pnas.1415675112","article-title":"Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis","volume":"112","author":"Harbour","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.06.927_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frosteg\u00e5rd","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.06.927_bib46","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.atherosclerosis.2018.05.052","article-title":"Myeloid Kdm6b deficiency results in advanced atherosclerosis","volume":"275","author":"Neele","year":"2018","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.06.927_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064436","article-title":"Peroxisome proliferator-activated receptor \u03b4 agonist, HPP593, prevents renal necrosis under chronic ischemia","volume":"8","author":"Fedorova","year":"2013","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2021.06.927_bib48","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/01.ATV.0000173413.31789.1a","article-title":"Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL\/6 and low-density lipoprotein receptor-deficient mice","volume":"25","author":"Babaev","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.06.927_bib49","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/j.1471-4159.2007.04875.x","article-title":"Peroxisome proliferator-activated receptor-alpha agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis","volume":"103","author":"Xu","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.atherosclerosis.2021.06.927_bib50","doi-asserted-by":"crossref","first-page":"8326749","DOI":"10.1155\/2017\/8326749","article-title":"PPAR-y activation prevents septic cardiac dysfunction via inhibition of apoptosis and necroptosis","author":"Peng","year":"2017","journal-title":"Oxid Med Cell Longev"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021012168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021012168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:46:58Z","timestamp":1758156418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915021012168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":50,"alternative-id":["S0021915021012168"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.06.927","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid-associated lipin-1 transcriptional co-regulatory activity is atheroprotective","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.06.927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}